NEW YORK (TheStreet) -- Novartis (NVS - Get Report) stock is gaining on Tuesday after announcing a series of major deals with GlaxoSmithKline (GSK) and Eli Lilly (LLY) which will reshape the pharmaceutical industry.
By midday, shares had added 1.2% to $86.46.
Swiss firm Novartis said it would purchase GSK's oncology portfolio for $14.5 billion, plus an additional $1.5 billion pending results from key cancer drug trials. The purchase of that division will bolster its position as the second-biggest pharmaceutical player in oncology behind Roche Holding.
WATCH: More market update videos on TheStreet TV
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts